Skip to main content
Log in

Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells

Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

The purpose of this study was to determine whether the expression of theJE/MCP-1 gene encoding for the monocyte chemottractant protein, MCP-1 (also known as monocyte chemotactic and activating factor MCAF, TDCF, and SMC-CF) can influence the metastatic properties of tumor cells. The highly metastatic murine colon carcinoma CT-26 cells, syngeneic to BALB/c mice that do not produce endogenous JE/MCP-1 protein, were transfected with a BCMGS-Neo expression vector (control) or a vector containing full-lengthJE cDNA. CT-26 parental cells, CT-26 Neo, and CT-26 JE/MCP-1-positive cells were injected into syngeneic or nude mice. The CT-26 JE/MCP-1-positive cells produced significantly fewer lung metastases. The decrease in incidence of metastasis was not due to the inability of the transfected cells to arrest in the lung vasculature or to differences in cell cycle time. CT-26 cells producing JE/MCP-1 were highly susceptible to lysis by syngeneic macrophages treated with subthreshold concentrations of lipopolysaccharide. In addition, culture supernatants of JE/MCP-1-expressing cells plus lipopolysaccharide synergistically activated tumoricidal properties in syngeneic macrophages. This activity was blocked by anti-JE/MCP-1 antibodies, indicating the involvement of the JE/MCP-1 molecule in this process. Moreover, purified JE/MCP-1 added to lipopolysaccharide-containing medium resulted in significant activation of macrophages against parental CT-26 cells. These data suggest that, in addition to its chemotactic properties, JE/MCP-1 can synergize with bacterial endotoxins to activate macrophages to become tumoricidal and, hence, could suppress metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bar-Eli M, Gallily R (1975). The effect of macrophage hydrolytic enzyme levels on the uptake and degradation of antigen and immune complexes. J Reticuloendothel Soc 18: 317

    PubMed  Google Scholar 

  2. Benomar A, Wang JM, Taraboletti G, Ghezzi P, Balotta C, Cianciolo GJ, Snyderman R, Dore JF, Mantovani A (1987) Chemotactic factors and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. J Immunol 136: 2372

    Google Scholar 

  3. Bottazzi B, Polentarutti N, Balsari A, Boraschi D, Ghezzi P, Salmona M, Mantovani A (1983) Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer 31: 55

    PubMed  Google Scholar 

  4. Bottazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P, Salmona M, Mantovani A (1983) Regulation of macrophage content of neoplasms by chemoattractants. Science 220: 210

    PubMed  Google Scholar 

  5. Bottazzi B, Ghezzi P, Taraboletti G, Salmona M, Colombo N, Bonazzi C, Mangioni C, Mantovani A (1985) Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer 36: 167

    PubMed  Google Scholar 

  6. Bottazzi B, Walter S, Govoni D, Collota F, Mantovani A (1992) Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth and susceptibility to IL-2 therapy of a murine melanoma. J Immunol 148: 1280

    PubMed  Google Scholar 

  7. Bottazzi B, Colotta F, Sica A, Nobili N, Mantovani A (1990) A chemoattractant expressed in human sarcoma cell (tumor-derived chemotactic factor, TCDF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer 45: 795

    PubMed  Google Scholar 

  8. Cochran BH, Reffel AC, Stiles CD (1983) Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33: 939

    PubMed  Google Scholar 

  9. Corbett TH, Griswold DP Jr, Roberts BJ (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays with a note on carcinogen structure. Cancer Res 23: 2434

    Google Scholar 

  10. Drysdale BE, Agarwal S, Shin HS (1988) Macrophage-mediated tumoricidal activity: mechanisms of activation and cytotoxicity. Prog Allergy 40: 111

    PubMed  Google Scholar 

  11. Esumi N, Fan D, Fidler IJ (1991) Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res 51: 4549

    PubMed  Google Scholar 

  12. Fidler IJ (1970) Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with125I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 45: 773

    PubMed  Google Scholar 

  13. Fidler IJ (1985) Macrophages and metastasis—a biological approach to cancer therapy: presidential address. Cancer Res 45: 4714

    PubMed  Google Scholar 

  14. Fidler IJ (1986) Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5: 29

    PubMed  Google Scholar 

  15. Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50: 6130

    PubMed  Google Scholar 

  16. Fidler IJ, Gersten DM, Kripke ML (1979) The influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities. Cancer Res 39: 3816

    PubMed  Google Scholar 

  17. Furutani Y, Nomura H, Notake M, Oyamada Y, Fukui T, Yamada M, Larsen CGG, Oppenheim JJ, Matsushima K (1989) Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun 159: 249

    PubMed  Google Scholar 

  18. Gallily R, Bar-Eli M (1976) Studies on the relationships between the immunogenicity and catabolism of antigens and their binding to the surface of macrophages. Eur J Immunol 6: 789

    PubMed  Google Scholar 

  19. Graves D, Jiang TYL, Williamson A, Valente AJ (1989) Identification of monocyte chemotactic activity produced by malignant cells. Science 245: 1490

    PubMed  Google Scholar 

  20. Huang S, Paulauskis JD, Godleski JJ, Kobzik L (1992) Expression of macrophages inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 141: 981

    PubMed  Google Scholar 

  21. Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M (1993) Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 3: 35

    PubMed  Google Scholar 

  22. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor associated macrophages. Immunol Today 13: 265

    PubMed  Google Scholar 

  23. Matsushima K, Larsen CG, Dubois CG, Oppenheim JJ (1989) Purification and characterization of a novel monocyte chemotactic protein and activating factor produced by a human myelo-monocytic cell line. J Exp Med 169: 1485

    PubMed  Google Scholar 

  24. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 9: 617

    PubMed  Google Scholar 

  25. Raz A, Fogler WE, Fidler IJ (1979) The effect of experimental condition on the expression of in vitro tumor cytotoxicity mediated by murine macrophages. Cancer Immunol Immunother 7: 157

    Google Scholar 

  26. Rollins BJ, Sunday ME (1991) Suppression of tumor formation in vivo by expression of the JE genes in malignant cells. Mol Cell Biol 11: 3125

    PubMed  Google Scholar 

  27. Rollins BJ, Morrison ED, Stiles CD (1988) Cloning and expression of JE, a gene inducible by platet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA 85: 3738

    PubMed  Google Scholar 

  28. Saiki I, Fidler IJ (1979) Synergistic activation of recombinant mouse gamma interferon and muramyl dipeptide of tumoricidal properties in mouse macrophages. J Immunol 135: 604

    Google Scholar 

  29. Schackert H, Fidler IJ (1989) Development of an animal model to study the biology of recurrent colorectal cancer originating from mesenteric lymph system metastasis. Int J Cancer 44: 177

    PubMed  Google Scholar 

  30. Singh RK, Berry K, Matsushima N, Mukaida N, Fidler IJ (1993) Synergism between human monocyte chemotactic and activating factor (MCAF) and bacterial products for activation of tumoricidal properties in murine macrophages. J Immunol 151: 2786

    PubMed  Google Scholar 

  31. Sone S, Fidler IJ (1982) In situ activation of tumoricidal properties in rat alveolar macrophages and rejection of experimental lung metastases by intravenous injections ofNocardia rubra cell wall skeleton. Cancer Immunol Immunother 9: 227

    Google Scholar 

  32. Van Damme J, Decock B, Lenaerts JP, Conings R, Bertini R, Mantovani A, Billiau A (1989) Identification by sequence analysis of chemotactic factors for monocytes produced by normal transformed cells stimulated with virus, double stranded RNA or IL-1. Eur J Immunol 19: 2367

    PubMed  Google Scholar 

  33. Van Damme J, Decok B, Bertini R, Conings R, Leanerts JP, Put W, Opdenakker G, Mantovani A (1991) Production and identification of natural monocyte chemotactic protein (MCP) from virally infected fibroblasts. Relationship with the JE gene product. Eur J Biochem 199: 223

    PubMed  Google Scholar 

  34. Walter S, Bottazi B, Govoni D, Colotta F, Mantovani A (1991) Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int J Cancer 49: 431

    PubMed  Google Scholar 

  35. Wang JM, Cianciolo GJ, Snyderman R, Mantovani A (1986) Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. J Immunol 137: 2726

    PubMed  Google Scholar 

  36. Widner U, Manogua KR, Cerami A, Sherry B (1993) Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP-2, MIP-1, and MIP-1-beta, members of the chemokine superfamily of proinflammatory cytokines. J Immunol 150: 11

    Google Scholar 

  37. Xia YY, Feng LL, Yoshimura T, Wilson CB (1993) LPS-induced MCP-1, IL-1-beta, and TNF-alpha messenger RNA expression in isolated erythrocyte-perfused rat kidney. Am J Physiol 264: 5

    Google Scholar 

  38. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J-I, Leonard EJ (1989) Purification and amino acid analysis of two glioma-derived monocyte chemoattractants. J Exp Med 169: 1449

    PubMed  Google Scholar 

  39. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman M, Leonard EJ (1989) Human monocyte chemoattractant protein-1 (MCP-1): Full-length cDNA cloning, expression in mitogen-stimulated bloodmononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 244: 487

    PubMed  Google Scholar 

  40. Zachariae COC, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ, Matsushima K (1990) Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 171: 2177

    PubMed  Google Scholar 

  41. Zhang RD, Price JE, Schackert G, Itoh K, Fidler IJ (1991) Malignant potential of cells isolated from lymph nodes or brain metastases of melanoma patients and implications for prognosis. Cancer Res 51: 2029

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, S., Singh, R.K., Xie, K. et al. Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol Immunother 39, 231–238 (1994). https://doi.org/10.1007/BF01525986

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01525986

Key words

Navigation